The government has shaken up the UK research system. But fossil fuels, not low-carbon technologies, still seem to be in the driving seat.
A new report by Richard Jones and James Wilsdon invites us to question the biomedical bubble – the slow but steady concentration of research and development (R&D) resources in the hands of biomedical science.
A provocative case, it’s already generated some discussion. Here, I want to pick up a point that might be easily missed amongst fights over the role of biomedicine: the all-too-small amount of resource being put towards decarbonising energy.